| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5691048 | Contraception | 2016 | 39 Pages |
Abstract
Limited quality and quantity evidence on use of psychotropic drugs and HCs suggests low concern for clinically significant interactions, though no data exist specifically for non-oral formulations of HC. Given the high frequency of use for both HCs and psychotropic drugs among reproductive-age women in the US, this review highlights a need for further research in this area.
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Erin N. Berry-Bibee, Myong-Jin Kim, Katharine B. Simmons, Naomi K. Tepper, Halley E.M. Riley, H. Pamela Pagano, Kathryn M. Curtis,